Pfizer Vaccine Bonanza Slows — But Bill Gates Sold Early, Made Huge Profits
(The Defender) Pfizer on Tuesday announced 2022 profits of $31.4 billion on record sales of $100.3 billion. Sales from its COVID-19 vaccine and Paxlovid, used to treat COVID-19, totaled $56 billion — more than half the vaccine maker’s annual revenue.
However, the company warned investors to expect sales of those two products to plummet up to 58% in 2023, to only about $21.5 billion — $3 billion short of Wall Street projections. Pfizer projected total 2023 revenue of only about $67-$71 billion.---More...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy